发明名称 Fucosylation-deficient cells
摘要 An isolated nucleic acid encoding an FX protein having a serine at position 79, a lysine at position 90, a leucine at position 136, an arginine at position 211, a serine at position 289, and a combination thereof is provided. Cells having a gene encoding a modified FX protein are provided, wherein the cells exhibit a reduced ability to fucosylate a glycoprotein at a first temperature, but exhibit the ability to fucosylate the glycoprotein at a second temperature. Methods and compositions for making glycoproteins with reduced fucosylation are provided.
申请公布号 US9550823(B2) 申请公布日期 2017.01.24
申请号 US201514963178 申请日期 2015.12.08
申请人 REGENERON PHARMACEUTICALS, INC. 发明人 Chen Gang;Burakov Darya;Fandl James P.
分类号 C12P21/04;C12N9/02;C12N15/00;C12N1/20;C07H21/04;C07K16/00;C07K16/28;C12N9/04;C12P21/00 主分类号 C12P21/04
代理机构 Scully, Scott, Murphy & Presser, P.C. 代理人 Scully, Scott, Murphy & Presser, P.C. ;Johnson Mary
主权项 1. A method for making a glycoprotein with reduced fucosylation, comprising: culturing a mammalian cell that expresses a GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase (FX) protein comprising the amino acid sequence of SEQ ID NO: 1, except for an amino acid substitution of L289S, at a temperature of about 37° C. and in the absence of an external fucose source, wherein the cell expresses a glycoprotein; and, isolating the glycoprotein from the culture.
地址 Tarrytown NY US